Cargando…

Expression of the endocannabinoid system and response to cannabinoid components by the human fetal testis

BACKGROUND: Cannabis consumption by pregnant women continues to increase worldwide, raising concerns about adverse effects on fetal growth and deleterious impacts on the newborn, in connection with evidence of placental transfer of cannabis compound. Cannabis action is mediated by the endocannabinoi...

Descripción completa

Detalles Bibliográficos
Autores principales: Dochez-Arnault, J., Desdoits-Lethimonier, C., Matias, I., Evrard, B., Lagarrigue, M., Toupin, M., Lardenois, A., Chalmel, F., Mazaud-Guittot, S., Dejucq-Rainsford, N., Gely-Pernot, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10334520/
https://www.ncbi.nlm.nih.gov/pubmed/37430350
http://dx.doi.org/10.1186/s12916-023-02916-5
_version_ 1785070873177227264
author Dochez-Arnault, J.
Desdoits-Lethimonier, C.
Matias, I.
Evrard, B.
Lagarrigue, M.
Toupin, M.
Lardenois, A.
Chalmel, F.
Mazaud-Guittot, S.
Dejucq-Rainsford, N.
Gely-Pernot, A.
author_facet Dochez-Arnault, J.
Desdoits-Lethimonier, C.
Matias, I.
Evrard, B.
Lagarrigue, M.
Toupin, M.
Lardenois, A.
Chalmel, F.
Mazaud-Guittot, S.
Dejucq-Rainsford, N.
Gely-Pernot, A.
author_sort Dochez-Arnault, J.
collection PubMed
description BACKGROUND: Cannabis consumption by pregnant women continues to increase worldwide, raising concerns about adverse effects on fetal growth and deleterious impacts on the newborn, in connection with evidence of placental transfer of cannabis compound. Cannabis action is mediated by the endocannabinoid system (ECS), which expression is well established in the brain but unknown in the developing testis. The fetal testis, whose endocrine function orchestrates the masculinization of many distant organs, is particularly sensitive to disruption by xenobiotics. In this context, we aimed to determine whether cannabis exposure has the potential to directly impact the human fetal testis. METHODS: We determined the expression of components of the ECS in the human fetal testis from 6 to 17 developmental weeks and assessed the direct effects of phytocannabinoids Δ9-trans-tetrahydrocannabinol (THC) and cannabidiol (CBD) on the testis morphology and cell functions ex vivo. RESULTS: We demonstrate the presence in the human fetal testis of two key endocannabinoids, 2-arachidonylglycerol (2-AG) and to a lower level anandamide (AEA), as well as a range of enzymes and receptors for the ECS. Ex vivo exposure of first trimester testes to CBD, THC, or CBD/THC [ratio 1:1] at 10(−7) to 10(−5) M altered testosterone secretion by Leydig cells, AMH secretion by Sertoli cells, and impacted testicular cell proliferation and viability as early as 72 h post-exposure. Transcriptomic analysis on 72 h-exposed fetal testis explants revealed 187 differentially expressed genes (DEGs), including genes involved in steroid synthesis and toxic substance response. Depending on the molecules and testis age, highly deleterious effects of phytocannabinoid exposure were observed on testis tissue after 14 days, including Sertoli and germ cell death. CONCLUSIONS: Our study is the first to evidence the presence of the ECS in the human fetal testis and to highlight the potential adverse effect of cannabis consumption by pregnant women onto the development of the male gonad. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12916-023-02916-5.
format Online
Article
Text
id pubmed-10334520
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-103345202023-07-12 Expression of the endocannabinoid system and response to cannabinoid components by the human fetal testis Dochez-Arnault, J. Desdoits-Lethimonier, C. Matias, I. Evrard, B. Lagarrigue, M. Toupin, M. Lardenois, A. Chalmel, F. Mazaud-Guittot, S. Dejucq-Rainsford, N. Gely-Pernot, A. BMC Med Research Article BACKGROUND: Cannabis consumption by pregnant women continues to increase worldwide, raising concerns about adverse effects on fetal growth and deleterious impacts on the newborn, in connection with evidence of placental transfer of cannabis compound. Cannabis action is mediated by the endocannabinoid system (ECS), which expression is well established in the brain but unknown in the developing testis. The fetal testis, whose endocrine function orchestrates the masculinization of many distant organs, is particularly sensitive to disruption by xenobiotics. In this context, we aimed to determine whether cannabis exposure has the potential to directly impact the human fetal testis. METHODS: We determined the expression of components of the ECS in the human fetal testis from 6 to 17 developmental weeks and assessed the direct effects of phytocannabinoids Δ9-trans-tetrahydrocannabinol (THC) and cannabidiol (CBD) on the testis morphology and cell functions ex vivo. RESULTS: We demonstrate the presence in the human fetal testis of two key endocannabinoids, 2-arachidonylglycerol (2-AG) and to a lower level anandamide (AEA), as well as a range of enzymes and receptors for the ECS. Ex vivo exposure of first trimester testes to CBD, THC, or CBD/THC [ratio 1:1] at 10(−7) to 10(−5) M altered testosterone secretion by Leydig cells, AMH secretion by Sertoli cells, and impacted testicular cell proliferation and viability as early as 72 h post-exposure. Transcriptomic analysis on 72 h-exposed fetal testis explants revealed 187 differentially expressed genes (DEGs), including genes involved in steroid synthesis and toxic substance response. Depending on the molecules and testis age, highly deleterious effects of phytocannabinoid exposure were observed on testis tissue after 14 days, including Sertoli and germ cell death. CONCLUSIONS: Our study is the first to evidence the presence of the ECS in the human fetal testis and to highlight the potential adverse effect of cannabis consumption by pregnant women onto the development of the male gonad. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12916-023-02916-5. BioMed Central 2023-07-11 /pmc/articles/PMC10334520/ /pubmed/37430350 http://dx.doi.org/10.1186/s12916-023-02916-5 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Dochez-Arnault, J.
Desdoits-Lethimonier, C.
Matias, I.
Evrard, B.
Lagarrigue, M.
Toupin, M.
Lardenois, A.
Chalmel, F.
Mazaud-Guittot, S.
Dejucq-Rainsford, N.
Gely-Pernot, A.
Expression of the endocannabinoid system and response to cannabinoid components by the human fetal testis
title Expression of the endocannabinoid system and response to cannabinoid components by the human fetal testis
title_full Expression of the endocannabinoid system and response to cannabinoid components by the human fetal testis
title_fullStr Expression of the endocannabinoid system and response to cannabinoid components by the human fetal testis
title_full_unstemmed Expression of the endocannabinoid system and response to cannabinoid components by the human fetal testis
title_short Expression of the endocannabinoid system and response to cannabinoid components by the human fetal testis
title_sort expression of the endocannabinoid system and response to cannabinoid components by the human fetal testis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10334520/
https://www.ncbi.nlm.nih.gov/pubmed/37430350
http://dx.doi.org/10.1186/s12916-023-02916-5
work_keys_str_mv AT dochezarnaultj expressionoftheendocannabinoidsystemandresponsetocannabinoidcomponentsbythehumanfetaltestis
AT desdoitslethimonierc expressionoftheendocannabinoidsystemandresponsetocannabinoidcomponentsbythehumanfetaltestis
AT matiasi expressionoftheendocannabinoidsystemandresponsetocannabinoidcomponentsbythehumanfetaltestis
AT evrardb expressionoftheendocannabinoidsystemandresponsetocannabinoidcomponentsbythehumanfetaltestis
AT lagarriguem expressionoftheendocannabinoidsystemandresponsetocannabinoidcomponentsbythehumanfetaltestis
AT toupinm expressionoftheendocannabinoidsystemandresponsetocannabinoidcomponentsbythehumanfetaltestis
AT lardenoisa expressionoftheendocannabinoidsystemandresponsetocannabinoidcomponentsbythehumanfetaltestis
AT chalmelf expressionoftheendocannabinoidsystemandresponsetocannabinoidcomponentsbythehumanfetaltestis
AT mazaudguittots expressionoftheendocannabinoidsystemandresponsetocannabinoidcomponentsbythehumanfetaltestis
AT dejucqrainsfordn expressionoftheendocannabinoidsystemandresponsetocannabinoidcomponentsbythehumanfetaltestis
AT gelypernota expressionoftheendocannabinoidsystemandresponsetocannabinoidcomponentsbythehumanfetaltestis